Integrated Pharmaceutical Market A database of China's integrated pharmaceutical market information
Supporting companies' research and sales decisions for the integrated pharmaceutical market
Retail channel data is now available
Log In
Free Trial
An all-in-one data service platform for China's pharmaceutical market
information that allows you to understand the pattern of the drug market
PharmaBI™ IPM collects multi-dimensional drug information from China's integrated pharmaceutical market
and supports labeling data with information such as new drug, marketing application, bidding, medical insurance and centralized procurement, allowing users to have an overview of China's integrated pharmaceutical market, discover market potential, and grasp the trends.
Hospital Channel
Retail Channel
Sample Provinces
30
Sample Cities
330+
The transaction data sourced from 220 million retail pharmacy memberships
GMV of Sample
80 billion+
Number of drugs
100,000+
Comprehensive drug classification tags from Pharmacube
Number of Sample Pharmacies
100,000+
Number of Sample Chain Pharmacies
1800+
Restoring a fully pharmacy sales through scientific data modeling
Region Coverage: 31 Provinces
HCO Coverage: All hospitals with over 100 beds
Time Granularity: Quarter
Update Speed: 55 days after the end of the quarter
Data type: Purchasing data of hospital
Basic Info
Drug name, Chemical name, Generic name, Brand name, Dosage forms, Specifications…
Drug structure: Peptide、Nucleotide、Cell therapy...
Rx/OTC、CN launched year、Consistency evaluation
Market Classification
Target、ATC、CHS drug classification
Policy labels
VBP、NRDL Catalog Composition
PharmaBI™ IPM unveils the potential and trends of China's drug
market.
Built based on Microsoft Power BI and characterized by its interactive data visualization functions, PharmaBI™ IPM is committed to helping users grasp the landscape of China's integrated pharmaceutical market.
